Financials
- Market Capitalization 11.35 M
- Employee 8
- Founded 2011
- CEO Paul Kang
- Website www.exicuretx.com
- Headquarter Delaware, United States
- FIGI BBG00GTJCSB4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.86
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4796 | KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.51 USD | +2.03% | -1.95% | -1.57% | +19.52% | 11.12 M USD | ||
| 4802 | TRAW Traws Pharma, Inc. - Common Stock | 0.71 USD | +4.41% | -2.74% | -34.86% | -54.19% | 10.76 M USD | ||
| 4806 | TOVX Theriva Biologics, Inc. Common Stock | 0.25 USD | +8.70% | +8.70% | -13.79% | +0.97% | 11.47 M USD | ||
| 4811 | VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.24 USD | -4.00% | 0.00% | -59.32% | -53.41% | 9.85 M USD |